Hawaii Cancer Care

Honolulu, Hawaii 96813

4 studies enrolling now · 13 studies all time

What they study most

Advanced or Metastatic Solid Tumors, Bile Duct Cancer, Bladder Cancer, Breast Cancer, Breast Tumor, Cancer, Chemotherapy Induced Peripheral Neuropathy (CIPN), Cholangiocarcinoma, Colon Tumor, Malignant, Colorectal Cancer, Coronavirus, Early Breast Cancer

Studies at this site

• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study — Recruiting now
• GEMINI-NSCLC: NSCLC Biomarker Study — Recruiting now
• A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
• Umbrella Study for Analysis of Data Related to Patients With Cancer — Completed
• An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma — Running, not enrolling
• ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer — Available (expanded access)
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
• Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors — Stopped early
• A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer — Completed
• ASCO Survey on COVID-19 in Oncology (ASCO) Registry — Status unconfirmed
• KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC — Stopped early
• Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208) — Stopped early